Abstract:Multidrug resistant (MDR) Klebsiella pneumoniae is a major cause of healthcare-associated infections around the world, with attendant high rates of morbidity and mortality. Progressive reduction in potency of antibiotics capable of treating MDR K. pneumoniae infections - including lung infection - as a consequence of escalating drug resistance provides the motivation to develop drug candidates targeting MDR K. pneumoniae. We recently reported degradable broad-spectrum antimicrobial guanidinium-functionalized polycarbonates with unique antimicrobial mechanism - membrane translocation followed by precipitation of cytosolic materials. These polymers exhibited high potency against bacteria with negligible toxicity. The polymer with ethyl spacer between the quanidinium group and the polymer backbone (pEt_20) showed excellent in vivo efficacy for treating MDR K. pneumoniae-caused peritonitis in mice. In this study, the structures of the polymers were optimized for the treatment of MDR Klebsiella pneumoniae lung infection. Specifically, in vitro antimicrobial activity and selectivity of guanidinium-functionalized polycarbonates containing the same number of guanidinium groups but of a shorter chain length and a structural analogue containing a thiouronium moiety as the pendent cationic group were evaluated. The polymers with optimal compositions and varying hydrophobicity were assessed against 25 clinically isolated K. pneumonia strains for antimicrobial activity and killing kinetics. The results showed that the polymers killed the bacteria more efficiently than clinically used antibiotics, and repeated use of the polymers did not cause drug resistance in K. pneumonia. Particularly, the polymer with butyl spacer (pBut_20) self-assembled into micelles at high concentrations, where the hydrophobic component was shielded in the micellar core, preventing interacting with mammalian cells. A subtle change in the hydrophobicity increased the antimicrobial activity while reducing in vivo toxicity. The in vivo efficacy studies showed that pBut_20 alleviated K. pneumonia lung infection without inducing damage to major organs. Taken together, pBut_20 is promising for treating MDR Klebsiella pneumoniae lung infection in vivo. STATEMENT OF SIGNIFICANCE: Multidrug resistant (MDR) Klebsiella pneumoniae is a major cause of healthcare-associated infections, with attendant high rates of morbidity and mortality. The progressive reduction in antibiotics capable of treating MDR K. pneumoniae infections - including lung infection - as a consequence of escalating drug resistance rates provides the motivation to develop drug candidates. In this study, we report a degradable guanidinium-functionalized polycarbonate with unexpected antimicrobial activity and selectivity towards MDR Klebsiella pneumoniae. A subtle change in polymer hydrophobicity increases antimicrobial activity while reducing in vivo toxicity due to self-assembly at high concentrations. The polymer with optimal composition alleviates Klebsiella pneumonia lung infection without inducing damage to major organs. The polymer is promising for treating MDR Klebsiella pneumoniae lung infection in vivo.

Antimicrobial Guanidinylate Polycarbonates Show Oral in Vivo Efficacy Against Clostridioides Difficile

Biodegradable Antimicrobial Polycarbonates with in Vivo Efficacy Against Multidrug‐Resistant MRSA Systemic Infection

A macromolecular approach to eradicate multidrug resistant bacterial infections while mitigating drug resistance onset

Degradable Antimicrobial Polycarbonates with Unexpected Activity and Selectivity for Treating Multidrug-Resistant Klebsiella Pneumoniae Lung Infection in Mice.

Polycarbonates with Potent and Selective Antimicrobial Activity Toward Gram-Positive Bacteria

Biodegradable nanostructures with selective lysis of microbial membranes

Cationic Homopolymers Inhibit Spore and Vegetative Cell Growth of Clostridioides difficile

Synthetic Polymers Active Against Clostridium Difficile Vegetative Cell Growth and Spore Outgrowth

Extensive in Vitro Activity of Guanidine Hydrochloride Polymer Analogs Against Antibiotics-Resistant Clinically Isolated Strains

Combination of Guanidinium and Quaternary Ammonium Polymers with Distinctive Antimicrobial Mechanisms Achieving a Synergistic Antimicrobial Effect.

Peptide-mimicking Poly(2-Oxazoline) Displaying Potent Antibacterial and Antibiofilm Activities Against Multidrug-Resistant Gram-positive Pathogenic Bacteria

Host Defense Peptide Mimicking Peptide Polymer Exerting Fast, Broad Spectrum, and Potent Activities Toward Clinically Isolated Multidrug-Resistant Bacteria.

Alternatingly Amphiphilic Antimicrobial Oligoguanidines: Structure–Property Relationship and Usage As the Coating Material with Unprecedented Hemocompatibility

Combination of Vancomycin and Guanidinium-Functionalized Helical Polymers for Synergistic Antibacterial Activity and Biofilm Ablation

Bis‐Cyclic Guanidines As a Novel Class of Compounds Potent Against Clostridium Difficile

A Dynamic Covalent Polymeric Antimicrobial for Conquering Drug‐resistant Bacterial Infection

Highly dynamic biodegradable micelles capable of lysing Gram-positive and Gram-negative bacterial membrane.

Poly(phosphonium)-Functionalized Double-Armed β-CD Antimicrobial Material via RAFT

Structural Superiority of Guanidinium-Rich, Four-Armed Copolypeptides: Role of Multiple Peptide-Membrane Interactions in Enhancing Bacterial Membrane Perturbation and Permeability.

Design and Synthesis of Biocompatible, Hemocompatible, and Highly Selective Antimicrobial Cationic Peptidopolysaccharides Via Click Chemistry

Optimizing the Bacteriostatic and Cytocompatibility Properties of Poly(hexamethylene guanidine) Hydrochloride (PHMG) via the Guanidine/Alkane Ratio